Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct;30(4):698-701.
doi: 10.3350/cmh.2024.0327. Epub 2024 May 7.

Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on "Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma"

Junlong Dai  1   2 , Jimmy Che-To Lai  1   2 , Grace Lai-Hung Wong  1   2 , Terry Cheuk-Fung Yip  1   2
Affiliations
Editorial

Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on "Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma"

Junlong Dai et al. Clin Mol Hepatol. 2024 Oct.
No abstract available

Keywords: Hepatocellular carcinoma; Liver cancer; Machine learning; Prognosis; Survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Junlon Dai declares that he has no conflicts of interest.

Jimmy Lai has served as a speaker for Gilead Sciences and an advisory board committee for Gilead Sciences and Boehringer Ingelheim.

Grace Wong has served as an advisory committee member for AstraZeneca, Gilead Sciences and Janssen, and as a speaker for Abbott, AbbVie, Ascletis, Bristol-Myers Squibb, Echosens, Gilead Sciences, Janssen, and Roche. She has also received a research grant from Gilead Sciences.

Terry Yip has served as an advisory committee member and a speaker for Gilead Sciences.

Figures

Figure 1.
Figure 1.
Prediction of prognosis of patients with early hepatocellular carcinoma using machine learning models. BCLC, Barcelona Clinic of Liver Cancer; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

Comment on

References

    1. Reig M, Forner A, Rimola J, Ferrer-Fàbrega J, Burrel M, Garcia-Criado Á, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76:681–693. - PMC - PubMed
    1. Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400:1345–1362. - PubMed
    1. Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61:526–536. - PubMed
    1. Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550–558. - PMC - PubMed
    1. Demirtas CO, D’Alessio A, Rimassa L, Sharma R, Pinato DJ. ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma. JHEP Rep. 2021;3:100347. - PMC - PubMed

LinkOut - more resources